Evista and Estrostep 21 drug interactions - a phase IV clinical study of FDA data
Summary:
We study 25,952 people who take Evista (raloxifene hydrochloride) and Estrostep 21 (ethinyl estradiol; norethindrone acetate). There is no drug interaction reported.
The study analyzes what interactions people have when they take Evista and Estrostep 21. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Evista?
Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.
What is Estrostep 21?
Estrostep 21 has active ingredients of ethinyl estradiol; norethindrone acetate. eHealthMe is studying from 61 Estrostep 21 users. Check the latest studies of Estrostep 21.
No report is found.
Do you take Evista and Estrostep 21?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Evista (25,891 reports)
- Estrostep 21 (61 reports)
How the study uses the data?
The study uses data from the FDA. It is based on raloxifene hydrochloride and ethinyl estradiol; norethindrone acetate (the active ingredients of Evista and Estrostep 21, respectively), and Evista and Estrostep 21 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Allergic Rhinitis and Blood Creatine Phosphokinase Increased - 3 seconds ago
- Could Tracleer cause Dementia? - 21 seconds ago
- Could Cotrim cause Stress And Anxiety? - 24 seconds ago
- Drug interactions of Aranesp and Keppra - 24 seconds ago
- Drug interactions of Atacand and Neulasta - 24 seconds ago
- Drug interactions of Promethazine and Levaquin - 30 seconds ago
- Could Topamax cause Skin Irritation? - 33 seconds ago
- Drug interactions of Magnesium Oxide and Coq10 - 34 seconds ago
- Drug interactions of Simvastatin and Obeticholic Acid - 37 seconds ago
- Could Mayzent cause Gastric Ulcer? - 39 seconds ago